Digoxin in patients with atrial fibrillation and heart failure: A meta-analysis.

[1]  A. Farcomeni,et al.  Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation. , 2015, International journal of cardiology.

[2]  J. R. González-Juanatey,et al.  Seguimiento clínico de una muestra contemporánea de pacientes con fibrilación auricular en tratamiento con digoxina: resultados del estudio AFBAR , 2014 .

[3]  J. González-Juanatey,et al.  Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR study. , 2014, Revista espanola de cardiologia.

[4]  T. Chao,et al.  Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study. , 2014, The Canadian journal of cardiology.

[5]  C. Morgan,et al.  Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. , 2014, The American journal of cardiology.

[6]  M. Turakhia,et al.  Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. , 2014, Journal of the American College of Cardiology.

[7]  H. Behlouli,et al.  Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure. , 2014, The American journal of cardiology.

[8]  J. Cleland,et al.  Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. , 2013, European heart journal.

[9]  R. Charnigo,et al.  Increased mortality among patients taking digoxin--analysis from the AFFIRM study. , 2013, European heart journal.

[10]  Nancy M Albert,et al.  2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[11]  Judith S. Hochman,et al.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction , 2011 .

[12]  Ottavio Alfieri,et al.  Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420] , 2011 .

[13]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[14]  L. Fauchier,et al.  Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. , 2009, The American journal of cardiology.

[15]  B. Bozkurt,et al.  Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. , 2008, The American journal of cardiology.

[16]  H. Melhus,et al.  Digoxin and mortality in atrial fibrillation: a prospective cohort study , 2007, European Journal of Clinical Pharmacology.

[17]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[18]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[19]  M. Gheorghiade,et al.  WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .

[20]  B. Uretsky,et al.  Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. , 1993, Journal of the American College of Cardiology.

[21]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.